Financings associated with strategic advice
Press Releases
Strategic Advice: Dr. Rimm recently provided advisory services to Immuneering Corp. The team raised a Series A round of $20M in January 2020 and a Series B round of $62M in January 2021. Immuneering had an IPO on July 30, 2021, and Immuneering (IMRX) now trades on the Nasdaq exchange.
“Ilonna’s insights come from her work in investment banks, where she worked among traders, salespeople, equity analysts and bankers. She knows how investors think. Ilonna accelerates financing due to her commitment to translation of ‘investor language.’”
— Biotech CEO